EUVIMEDEUVIMED entdecken
LeserbriefSystematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

Comments on “Neurological efficacy and safety of RNA therapeutics in hereditary transthyretin amyloidosis: a systematic review and meta-analysis of randomized controlled trials”

Ankur Sharma, Varshini Vadhithala, Arun Kumar, Sushma Verma, Sushma Narsing Katkuri iD

Therapeutic Advances in Cardiovascular Disease · 2026-05 · 20

DOI: 10.1177/17539447261453501 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Therapeutic Advances in Cardiovascular Disease, online erschienen am 21.05.2026. Verfasst von Ankur Sharma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, School of Medical Sciences and Research, Sharda University, Greater Noida, India. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Anatomy, School of Medical Sciences and Research, Sharda University, Greater Noida, India.
  • Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed-to-be-University), Pimpri, Pune, Pimpri-Chinchwad, Maharashtra, India.
  • Faculty of Pharmaceutical Sciences, Graphic Era Hill University, Dehradun, India.
  • Centre for Promotion of Research, Graphic Era Deemed University, Dehradun, India.
  • Department of Pharmaceutics, Noida Institute of Engineering & Technology (Pharmacy Institute), Greater Noida, India.
  • Department of Community Medicine, Malla Reddy Institute of Medical Sciences, Malla Reddy Vishwavidyapeeth, Suraram, Hyderabad 500055, Telangana, India.

ORCID-Profile: Sushma Narsing Katkuri

Zitieren

APA

Sharma, A., Vadhithala, V., Kumar, A., Verma, S., & Katkuri, S. N. (2026). Comments on “Neurological efficacy and safety of RNA therapeutics in hereditary transthyretin amyloidosis: a systematic review and meta-analysis of randomized controlled trials”. Therapeutic Advances in Cardiovascular Disease, 20. https://doi.org/10.1177/17539447261453501

Vancouver

Sharma A, Vadhithala V, Kumar A, Verma S, Katkuri SN. Comments on “Neurological efficacy and safety of RNA therapeutics in hereditary transthyretin amyloidosis: a systematic review and meta-analysis of randomized controlled trials”. Therapeutic Advances in Cardiovascular Disease. 2026;20. doi:10.1177/17539447261453501

BibTeX
@article{Sharma2026,
  author = {Sharma, Ankur and Vadhithala, Varshini and Kumar, Arun and Verma, Sushma and Katkuri, Sushma Narsing},
  title = {Comments on “Neurological efficacy and safety of RNA therapeutics in hereditary transthyretin amyloidosis: a systematic review and meta-analysis of randomized controlled trials”},
  journal = {Therapeutic Advances in Cardiovascular Disease},
  year = {2026},
  volume = {20},
  doi = {10.1177/17539447261453501}
}
Kostenlos starten →